PURIFIED CORTROPHIN GEL Drug Patent Profile
✉ Email this page to a colleague
When do Purified Cortrophin Gel patents expire, and what generic alternatives are available?
Purified Cortrophin Gel is a drug marketed by Ani Pharms and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in PURIFIED CORTROPHIN GEL is corticotropin. There are ten drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the corticotropin profile page.
DrugPatentWatch® Generic Entry Outlook for Purified Cortrophin Gel
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PURIFIED CORTROPHIN GEL?
- What are the global sales for PURIFIED CORTROPHIN GEL?
- What is Average Wholesale Price for PURIFIED CORTROPHIN GEL?
Summary for PURIFIED CORTROPHIN GEL
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 19 |
| Patent Applications: | 2,492 |
| What excipients (inactive ingredients) are in PURIFIED CORTROPHIN GEL? | PURIFIED CORTROPHIN GEL excipients list |
| DailyMed Link: | PURIFIED CORTROPHIN GEL at DailyMed |
Pharmacology for PURIFIED CORTROPHIN GEL
| Drug Class | Adrenocorticotropic Hormone |
US Patents and Regulatory Information for PURIFIED CORTROPHIN GEL
PURIFIED CORTROPHIN GEL is protected by forty-six US patents.
Patents protecting PURIFIED CORTROPHIN GEL
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ALLERGIC CONJUNCTIVITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ANTERIOR SEGMENT INFLAMMATION
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: ACUTE GOUTY ARTHRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: ANKYLOSING SPONDYLITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: JUVENILE RHEUMATOID ARTHRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: PSORIATIC ARTHRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: RHEUMATOID ARTHRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ATOPIC DERMATITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CHORIORETINITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DIFFUSE POSTERIOR UVEITIS AND CHOROIDITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DURING AN EXACERBATION OR AS MAINTENANCE THERAPY IN SELECTED CASES OF: SYSTEMIC DERMATOMYOSITIS (POLYMYOSITIS)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DURING AN EXACERBATION OR AS MAINTENANCE THERAPY IN SELECTED CASES OF: SYSTEMIC LUPUS ERYTHEMATOSUS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: IRIDOCYCLITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: IRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: KERATITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: OPTIC NEURITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SERUM SICKNESS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SEVERE ACUTE AND CHRONIC ALLERGIC AND INFLAMMATORY PROCESSES INVOLVING THE EYE AND ITS ADNEXA
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SEVERE ERYTHEMA MULTIFORME (STEVENS-JOHNSON SYNDROME)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SEVERE PSORIASIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SYMPTOMATIC SARCOIDOSIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TO INDUCE A DIURESIS OR A REMISSION OF PROTEINURIA IN THE NEPHROTIC SYNDROME WITHOUT UREMIA OF THE IDIOPATHIC TYPE OR THAT DUE TO LUPUS ERYTHEMATOSUS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: IRIDOCYCLITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: IRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: KERATITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: OPTIC NEURITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SERUM SICKNESS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SEVERE ACUTE AND CHRONIC ALLERGIC AND INFLAMMATORY PROCESSES INVOLVING THE EYE AND ITS ADNEXA
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SEVERE ERYTHEMA MULTIFORME (STEVENS-JOHNSON SYNDROME)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SEVERE PSORIASIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: SYMPTOMATIC SARCOIDOSIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TO INDUCE A DIURESIS OR A REMISSION OF PROTEINURIA IN THE NEPHROTIC SYNDROME WITHOUT UREMIA OF THE IDIOPATHIC TYPE OR THAT DUE TO LUPUS ERYTHEMATOSUS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ALLERGIC CONJUNCTIVITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ANTERIOR SEGMENT INFLAMMATION
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: ACUTE GOUTY ARTHRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: ANKYLOSING SPONDYLITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: JUVENILE RHEUMATOID ARTHRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: PSORIATIC ARTHRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: AS ADJUNCTIVE THERAPY FOR SHORT-TERM ADMINISTRATION (TO TIDE THE PATIENT OVER AN ACUTE EPISODE OR EXACERBATION) IN: RHEUMATOID ARTHRITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ATOPIC DERMATITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: CHORIORETINITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DIFFUSE POSTERIOR UVEITIS AND CHOROIDITIS
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DURING AN EXACERBATION OR AS MAINTENANCE THERAPY IN SELECTED CASES OF: SYSTEMIC DERMATOMYOSITIS (POLYMYOSITIS)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: DURING AN EXACERBATION OR AS MAINTENANCE THERAPY IN SELECTED CASES OF: SYSTEMIC LUPUS ERYTHEMATOSUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
